Bank of America AtriCure, Inc. - Common Stock · Transaction Mar 25, 2026 · Filed Date unavailable · $1,001 to $15,000
XNAS · ATRC
+0.40% · +$0.1800 · Vol Not reported
Pre-market · updated 04:05:34 ET
AtriCure, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$44.95
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · ATRC
MethodologyATRC
AtriCure, Inc.
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
64/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ATRC moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About AtriCure, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
2005
Employees
1K
Country
US
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$44.77
Last session
Day high
$44.77
Last session
Day low
$44.77
Last session
Previous close
$44.77
52W high
$44.95
0.00% from high
52W low
$25.86
100% of range
Market cap
$2.3B
P/E
1123.75×
EPS
$0.0400
Beta
-0.01
Shares out
50.9M
Avg volume
843.7K
VWAP
$44.77
Last session
Price history computed in-house
1W
+4.66%
1M
+28.61%
3M
+55.00%
1Y
+26.19%
YTD
+13.62%
SMA 50 $34.14 · above
SMA 200 $33.40 · above
52W position 100%
ATRC overview
Related filings and maps
Public disclosures
Congress activity in ATRC
Official filing ↗
ATRC · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
ATRC · Transaction May 6, 2025 · Filed Jun 6, 2025 · $1,001 to $15,000
AtriCure, Inc. - Common Stock · Transaction Jul 19, 2024 · Filed Aug 15, 2024 · $1,001 to $15,000
AtriCure, Inc. - Common Stock · Transaction Jun 18, 2024 · Filed Jul 9, 2024 · $1,001 to $15,000
Federal contracts
ATRC contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ATRC in this window.
Lobbying spend
ATRC lobbying filings, year to date.
Registered lobbying filings matched to AtriCure, Inc..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ATRC in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ATRC.
Options
Sovereign unlock shows live options positioning for ATRC.